Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002315713 | SCV000663133 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2016-08-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000681159 | SCV000808617 | likely benign | not provided | 2018-03-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001465391 | SCV001669376 | likely benign | Neurofibromatosis, type 1 | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821662 | SCV002068124 | likely benign | not specified | 2020-04-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001465391 | SCV002560813 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316736 | SCV004016452 | likely benign | Neurofibromatosis, familial spinal | 2023-07-07 | criteria provided, single submitter | clinical testing |